| Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models AS Leal, K Zydeck, S Carapellucci, LA Reich, D Zhang, JA Moerland, ... NPJ Breast Cancer 5 (1), 39, 2019 | 20 | 2019 |
| Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen GG Hillman, LA Reich, SE Rothstein, LM Abernathy, MD Fountain, ... Journal for Immunotherapy of Cancer 5, 1-13, 2017 | 19 | 2017 |
| Potential therapeutic uses of rexinoids AS Leal, LA Reich, JA Moerland, D Zhang, KT Liby Advances in Pharmacology 91, 141-183, 2021 | 15 | 2021 |
| The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer JA Moerland, D Zhang, LA Reich, S Carapellucci, B Lockwood, AS Leal, ... Scientific Reports 10 (1), 22244, 2020 | 11 | 2020 |
| The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer LA Reich, JA Moerland, AS Leal, D Zhang, S Carapellucci, B Lockwood, ... Scientific reports 12 (1), 293, 2022 | 8 | 2022 |
| The Novel RXR Agonist MSU-42011 Differentially Regulates Gene Expression in Mammary Tumors of MMTV-Neu Mice LA Reich, AS Leal, E Ellsworth, KT Liby International Journal of Molecular Sciences 24 (5), 4298, 2023 | 1 | 2023 |
| The novel rexinoid V-125 reduces tumor growth in the MMTV-Neu model of breast cancer and the A/J model of lung cancer via immunomodulation L Reich, J Moerland, AS Leal, D Zhang, S Carapellucci, CE Wagner, ... Cancer Research 82 (12_Supplement), 1118-1118, 2022 | | 2022 |
| Abstract B185: Induction of specific immunity to MUC1 antigen by tumor irradiation and cancer vaccines in murine tumor models GG Hillman, MD Fountain, SE Rothstein, L Reich, L Abernathy, ... Cancer Immunology Research 4 (1_Supplement), B185-B185, 2016 | | 2016 |
